Fate Therapeutics FATE
NASDAQ FATE
$2.30 -0.07 (-2.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Return on Equity [ROE] (2014 - 2026)

Updated

Fate Therapeutics (FATE) recorded Return on Equity [ROE] of -75.27% in Q2 2026, down 10.58 percentage points from -64.68% a year earlier and down 8.15 percentage points from the prior quarter.

Analysis

Fate Therapeutics (FATE) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Fate Therapeutics reported Return on Equity [ROE] of -51.97%, up 4.20 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of -12.02 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -56.17% in FY2024 (-15.50 pp), -40.67% in FY2023 (+11.37 pp), -52.04% in FY2022 (-11.47 pp) and -40.57% in FY2021 (-0.62 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q2 2018.
  • On a year-over-year basis, Return on Equity [ROE] has declined for eight consecutive quarters, with an average year-over-year change of -10.88 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 15.44 percentage points in Q4 2023, against a drop of 32.22 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -67.12% (Q1 2026), -61.94% (Q4 2025) and -65.41% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Fate Therapeutics 276.57 Mn 276.57 Mn - -75.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -75.27%
Mar 31, 2026 -67.12%
Dec 31, 2025 -61.94%
Sep 30, 2025 -65.41%
Jun 30, 2025 -64.68%
Mar 31, 2025 -60.62%
Dec 31, 2024 -56.67%
Sep 30, 2024 -47.09%
Jun 30, 2024 -43.11%
Mar 31, 2024 -49.17%
Dec 31, 2023 -44.95%
Sep 30, 2023 -45.50%
Jun 30, 2023 -50.09%
Mar 31, 2023 -52.71%
Dec 31, 2022 -60.39%
Sep 30, 2022 -56.46%
Jun 30, 2022 -46.10%
Mar 31, 2022 -37.17%
Dec 31, 2021 -30.61%
Sep 30, 2021 -24.24%
API Access

Fate Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=FATE&period=max&api_key=YOUR_API_KEY